The 5th Annual Cardiometabolic Risk in Inflammatory Conditions: Emerging Insights and Treatment of Inflammation in Cardiovascular Disease is dedicated to addressing the management of patients at elevated risk of cardiovascular and cardiometabolic disease linked to systemic inflammation.

The 5th Annual Cardiometabolic Risk in Inflammatory Conditions: Emerging Insights and Treatment of Inflammation in Cardiovascular Disease covers topics such as:

• Recent data linking systemic inflammation and cardiovascular disease
• Clinical trials targeting inflammation to reduce cardiovascular disease
• Novel techniques for imaging vasculature in vasculitis
• Updates in the clinical management of cardiovascular complications in autoimmune conditions
• Practical implications and guidelines on targeting inflammation with medications like colchicine
• Cases and practical lessons from cardio-rheumatology clinics

The 5th Annual Cardiometabolic Risk in Inflammatory Conditions: Emerging Insights and Treatment of Inflammation in Cardiovascular Disease brings together:

• Cardiologists
• Rheumatologists
• Gastroenterologists
• Internists
• General practitioners
• Family practitioners
• Nurse practitioners
• Nurses
• Physician trainees with an interest in cardio-inflammation

The 5th Annual Cardiometabolic Risk in Inflammatory Conditions: Emerging Insights and Treatment of Inflammation in Cardiovascular Disease might be held in Apr 2025.